Search Results

Drug Development

Phase 3 Trial Results for Stempeutics Cell Therapy in Knee Osteoarthritis Published in American Journal of Sports Medicine (AJSM)

Stempeutics, a leader in allogeneic cellular medicines for inflammatory diseases, announced the publication of the Knee OA Phase 3 trial results in the premier journal, the American Journal of Sports Medicine (AJSM).

August 23, 2023

·

2 min read

Cipla and Stempeutics collaborate for launch of Stempeucel®, first ‘Made in India’ Cell Therapy to treat Critical Limb Ischemia (CLI)

Developed by Stempeutics over a period of twelve years, breakthrough treatment designed to address root cause of the disease at an affordable cost

August 21, 2020

·

6 min read

FDA

Stempeutics Release: DCGI Gives Limited Approval To Market FIRST Allogeneic Cell Therapy Product In India Stempeutics Puts India On The ‘World Map Of Regenerative Medicine’

May 31, 2016

·

5 min read

Stempeutics Receives Japan Process Patent For Its Novel Stem Cell Drug ‘Stempeucel’

June 8, 2015

·

5 min read

Stempeutics Receives Orphan Drug Designation (ODD) In The European Union For Its Novel Stem Cell Drug “Stempeucel” For The Treatment Of Thromboangiitis Obliterans

June 1, 2015

·

5 min read

Policy

Stempeutics Receives Advanced Therapy Medicinal Product (ATMP) Classification From European Medicines Agency For Its Novel Stem Cell Drug ‘Stempeucel’

March 23, 2015

·

5 min read

Stempeutics Gets Stem Cell Patent In China (Chinese Application Number: CN201080053627) For Its Novel Stem Cell Drug ‘Stempeucel’

April 27, 2015

·

5 min read

Business

Stempeutics to Hunt for Tie-ups With Global Medical Device Majors for “Stempeutron”

April 6, 2012

·

1 min read

Allogeneic Cell Therapy Devices Market Poised for Significant Growth

The global allogeneic cell therapy devices market is growing at a strongest CAGR of 25.28% from 2023 to 2032.

April 8, 2024

·

13 min read

CAR T-Cell Therapy Market Size, Share, Growth, Trends, Report By 2032

The global CAR T-cell therapy market size was estimated at USD 2.20 billion in 2022 and it is expected to surpass around USD 6.48 billion by 2032, poised to grow at a CAGR of 11.4% from 2023 to 2032.

December 12, 2023

·

11 min read